Guide
503A vs. 503B compounding pharmacies explained
How the two U.S. compounding pharmacy categories differ in oversight, standards, and the products they prepare.
On this page
What compounding pharmacies do
Compounding is the practice of preparing a medication to fit a specific need — for example, combining ingredients, adjusting a strength, or changing a dosage form. In the United States, compounding pharmacies operate under a federal framework built on the Federal Food, Drug, and Cosmetic Act, which the Drug Quality and Security Act later amended to define two distinct categories: 503A and 503B. The labels come from the sections of that law. Understanding the difference helps explain who oversees a facility, how its preparations are made, and what standards apply. Compounded preparations are not the same as FDA-approved manufactured drugs; they are prepared under these compounding rules instead.
503A: patient-specific compounding
A 503A pharmacy performs traditional compounding: a licensed pharmacist or physician prepares a medication for an individual patient in response to a valid prescription. Preparations are made one patient at a time rather than in large stock batches. State boards of pharmacy are the primary regulators, setting licensing and practice standards, while the FDA retains authority over certain aspects, such as the bulk substances that may be used. These pharmacies are expected to follow United States Pharmacopeia (USP) standards, including separate chapters that address sterile and non-sterile preparation. Because the work is prescription-driven, a 503A preparation is tied to a named patient and a prescriber.
503B: registered outsourcing facilities
A 503B facility is an outsourcing facility that voluntarily registers with the FDA. Unlike traditional 503A compounding, a 503B facility may produce larger batches — in some cases without a prescription for an individual patient — so that clinics can keep certain preparations as office stock. In exchange, these facilities are held to Current Good Manufacturing Practice (cGMP), the same broad category of quality-system requirements applied to drug manufacturers, and are subject to direct FDA oversight, including facility inspections and adverse-event reporting. This category was designed to add a manufacturing-grade layer of oversight for facilities that prepare at scale.
What the categories mean for oversight
The two categories describe different oversight structures, not a ranking. A 503A pharmacy answers primarily to its state board of pharmacy and to USP standards; a 503B facility answers to the FDA under cGMP. Neither produces FDA-approved finished drugs, because compounded preparations are, by definition, prepared outside the approved-manufacturing pathway. Both frameworks are built around the same underlying goals: correct ingredients, appropriate handling, and — for injectables and other sterile products — controls intended to guard against contamination. If you want to understand how a specific medication is prepared, you can ask which category a pharmacy falls under and whether the preparation is sterile or non-sterile.
How ordering works on OpenDoseRx
Every medication offered through OpenDoseRx is a prescription product that requires review by an independent, licensed U.S. provider. You start by choosing the strength or option you are interested in, then complete a medical intake that asks about your health history. An independent provider reviews that information and decides whether a prescription is appropriate — this content is educational and does not substitute for that clinical judgment. If a prescription is written, it is sent to a licensed U.S. pharmacy for fulfillment and shipped to you. If the provider declines, you receive a full refund. This structure keeps the clinical decision with a licensed professional while the pharmacy handles preparation under the standards described above.
Common questions
- What is the difference between a 503A and 503B pharmacy?
- A 503A pharmacy compounds patient-specific preparations under state board of pharmacy oversight and USP standards, while a 503B outsourcing facility registers with the FDA and follows Current Good Manufacturing Practice (cGMP), which allows larger batches under direct federal oversight.
- Are compounded medications FDA-approved?
- No. Compounded preparations are made under 503A or 503B compounding rules and are not FDA-approved finished drugs, which follow a separate manufacturing and approval pathway.
- Does a 503A preparation require a prescription?
- Yes. 503A compounding is prescription-driven and tied to an individual, named patient, and a licensed provider must determine that the preparation is appropriate.
Browse treatments
Exact strengths and prices up front — reviewed by a licensed U.S. provider.
This guide is for general education and is not medical advice. Compounded medications are not FDA-approved drugs, and statements on this site have not been evaluated by the FDA. A licensed provider reviews every prescription request.